As a distributed infrastructure, ELIXIR has a mixed funding model with contributions coming from a number of mostly public sources:
- Collectively, the ELIXIR Hub and Nodes compete for grant funding from the European Union, under Horizon 2020 and the Innovative Medicine Initiative (IMI);
- The ELIXIR Hub is funded through membership fees paid by Member countries, and much of this funding is then transferred back to Nodes (e.g. via Implementation Studies) to deliver ELIXIR’s five-year Scientific Programme;
- ELIXIR Nodes are typically funded through national-level investments, supporting national coordination, and the development and operation of services;
- ELIXIR Nodes also receive support from international funders, such as the US’ National Institute of Health (NIH);
- Finally, some ELIXIR Nodes are able to access European Union Structural Funds, for instance to support national coordination and the purchasing of facilities.
Other sources of funding for Nodes include foundations (e.g. the Wellcome Trust and Wallenberg Foundation), and also the industry, though the latter is modest compared to the public funding received by Nodes.
ELIXIR's Sustainability Plan gives an overview of how ELIXIR intends to support the sustainability of the bioinformatics resources across its Nodes.